Global Research and Development Presence
We have a global research and development presence in key locations in Europe, North America and Asia. We are also investing in the innovation community by establishing hub activities in research ‘hot spots’ such as Boston, San Diego, New York, Vienna, Beijing and Kyoto. With extensive capabilities in both small molecules and biotherapeutics, our scientists are working in partnership with our growling global community of innovation partners to discover and develop medicines that improve patients’ lives.
Our Research and Development Locations
|
USA
Germany
Austria
Kobe, Japan
|
 |
In addition, we are proud of a number of long-term relationships with academic centers that go beyond the scope of individual research projects including our involvement with the Institute of Molecular Pathology (IMP) in Vienna, Austria.
These research activities are further supplemented by a growing global community of innovation partners that is an important part of our drug discovery and development efforts. With around 50% of our pipeline anchored firmly in external collaborations, this rich source of discovery and development is making a highly-valued contribution to our research and development portfolio. This is supported by industry-leading levels of investment totaling 20 billion euro*.
*Investment designated to 2025